Please can you explain how this report should guide my treatment, given that I am now technically NED following a...

I appreciate you sharing this context, but I notice I don't actually see the genomic report attached to your message. To give you the most helpful educational interpretation, I'll need you to upload the actual test results.

Could you please:

• Upload the genomic/expression profiler report (as a PDF, image, or document)
• Share any pathology reports from your lung ablation
• Include staging information if you have it (original cancer stage, sites of metastasis, etc.)

Once I can see your actual results, I'll be able to:

✅ Explain what the specific biomarkers mean for your colorectal cancer with lung metastasis
✅ Interpret how those findings typically guide treatment decisions in the NED setting
✅ Help you formulate targeted questions for your oncology team about adjuvant therapy options
✅ Reference NCCN Guidelines specific to your situation

---

In the Meantime — General Context About NED + Genomic Testing

Since you mentioned you're NED after lung ablation, here's what's typically important:

According to NCCN Guidelines for Metastatic Colorectal Cancer, patients who achieve NED status face a key decision point:

• Observation with surveillance vs. adjuvant (preventive) therapy
• Genomic biomarkers (like PD-L1, MSI status, TMB) help oncologists decide which patients benefit most from additional treatment

Your genomic profile is meant to predict which therapies your cancer cells are most likely to respond to — this directly informs whether immunotherapy, targeted therapy, or observation makes most sense for you.

Please upload your report and I'll give you a detailed, personalized educational interpretation!

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.